The accompanying table presents a full FDA calendar of decision dates updated through today, which I will maintain at the bottom of my blog in place of the previous Global Carbon Trading Index. Click on the calendar image above or on my blog to view or download the PDF version of the FDA calendar, which I will also maintain at: www.geocities.com/mikehavrx/fdac.pdf .
Several key decisions are pending through the end of this month for the group of 14 big pharma companies I outlined yesterday, including Eli Lilly (LLY) - Effient, Abbott Labs (ABT) - Vicodin CR, Schering-Plough (SGP) - asenapine, and GlaxoSmithKline (GSK) - Promacta.
Several key decisions are pending through the end of this month for the group of 14 big pharma companies I outlined yesterday, including Eli Lilly (LLY) - Effient, Abbott Labs (ABT) - Vicodin CR, Schering-Plough (SGP) - asenapine, and GlaxoSmithKline (GSK) - Promacta.
$44.55 (09/25/08)
